These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26707159)

  • 41. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A struggle to SURVIVE: to abandon or not to abandon levosimendan?
    Butler J; Giamouzis G; Giannakoulas G
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):401-2. PubMed ID: 17701453
    [No Abstract]   [Full Text] [Related]  

  • 43. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?
    Angadi U; Westrope C; Chowdhry MF
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):710-4. PubMed ID: 23832921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
    Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
    Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
    Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
    Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levosimendan increases bleeding risk after heart valve surgery: a retrospective analysis of a randomized trial.
    Lahtinen P; Pitkänen O; Musialowicz T
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1238-42. PubMed ID: 25281042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative levosimendan in heart failure patients undergoing noncardiac surgery.
    Katsaragakis S; Kapralou A; Markogiannakis H; Kofinas G; Theodoraki EM; Larentzakis A; Menenakos E; Theodorou D
    Neth J Med; 2008 Apr; 66(4):154-9. PubMed ID: 18424862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
    Bhattacharjee S; Soni KD; Maitra S; Baidya DK
    J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levosimendan in cardiac surgery: current best available evidence.
    Raja SG; Rayen BS
    Ann Thorac Surg; 2006 Apr; 81(4):1536-46. PubMed ID: 16564321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease].
    Fernández de Palencia-Espinosa MA; Cárceles-Barón MD; Blázquez-Álvarez MJ; Arocas-Casañ V; de la Rubia-Nieto A
    Rev Esp Anestesiol Reanim; 2012 Nov; 59(9):489-96. PubMed ID: 22980396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
    Lim JY; Deo SV; Rababa'h A; Altarabsheh SE; Cho YH; Hang D; McGraw M; Avery EG; Markowitz AH; Park SJ
    J Card Surg; 2015 Jul; 30(7):547-54. PubMed ID: 25989324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of levosimendan on prognosis in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.
    Chen QH; Zheng RQ; Lin H; Shao J; Yu JQ; Wang HL
    Crit Care; 2017 Oct; 21(1):253. PubMed ID: 29041948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.
    Landoni G; Biondi-Zoccai G; Greco M; Greco T; Bignami E; Morelli A; Guarracino F; Zangrillo A
    Crit Care Med; 2012 Feb; 40(2):634-46. PubMed ID: 21963578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
    Niu ZZ; Wu SM; Sun WY; Hou WM; Chi YF
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):107-12. PubMed ID: 24126568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Perioperative use of levosimendan in cardiac surgery. Hungarian recommendation].
    Szudi L; Székely L; Sápi E; Prodán Z; Szolnoky J; Csomós Á; Nyolczas N; Paulovich E; Németh E; Hartyánszky I; Zima E; Sax B; Bertalan A; Hejjel L; Bogáts G; Babik B; Gombocz K; Szerafin T; Koszta G; Molnár A
    Orv Hetil; 2018 Jun; 159(22):870-877. PubMed ID: 29806474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five-year mortality in cardiac surgery patients with low cardiac output syndrome treated with levosimendan: prognostic evaluation of NT-proBNP and C-reactive protein.
    Torrado H; Lopez-Delgado JC; Farrero E; Rodríguez-Castro D; Castro MJ; Periche E; Carriò ML; Toscano JE; Pinseau A; Javierre C; Ventura JL
    Minerva Cardioangiol; 2016 Apr; 64(2):101-13. PubMed ID: 26977768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A promising new inotrope: levosimendan.
    Fotbolcu H; Duman D
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.
    Rossinen J; Harjola VP; Siirila-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS
    Acute Card Care; 2008; 10(4):209-13. PubMed ID: 18720087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Useful supplement to the best practice of using levosimendan in cardiac surgery patients: 2.5-mg intravenous bolus for cardiopulmonary resuscitation during perioperative cardiac arrest.
    Carev M; Karanovic N; Kocen D; Bulat C
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):e75-7. PubMed ID: 24267577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.